Acepodia, Inc. (TPEX:6976)
Taiwan
· Delayed Price · Currency is TWD 12.75
+0.40 (3.24%)
Apr 29, 2026, 1:53 PM CST
Acepodia Revenue
In the year 2025, Acepodia had annual revenue of 185.00K TWD, down -56.67%.
Revenue
185.00K
Revenue Growth
-56.67%
P/S Ratio
38,867.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.19B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TaiGen Biopharmaceuticals Holdings | 259.47M |
| Adimmune | 1.40B |
| PharmaEngine | 911.42M |
| Gongwin Biopharm Holdings | 36.45M |
| Mycenax Biotech | 740.24M |
| Sinphar Pharmaceutical | 3.37B |
| Savior Lifetec | 1.20B |
| AnnJi Pharmaceutical | 7.55M |